Skip to content

Study of People's Profile Living in France Who Could be Interested in the Use of a Nanohydroxyapatite Toothpaste

Study of People's Profile Living in France Who Could be Interested in the Use of a Nanohydroxyapatite Toothpaste

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05234060
Enrollment
200
Registered
2022-02-10
Start date
2020-05-01
Completion date
2021-02-01
Last updated
2022-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries, Hydroxyapatite

Keywords

Cariostatic Agents, Toothpaste

Brief summary

Nano-hydroxyapatite is an interesting candidate to be a substitute for fluor in toothpastes or a complement to fluorides in order to prevent caries. The objective of this transversal descriptive study is to evaluate the profiles of people living in France who could be interested in using a nano-hydroxyapatite based toothpaste. Participants in this transversal descriptive study have been chosen by a self-administered method. Before answering 16 questions, the participants were asked to watch a short video describing the main concepts to know about fluoridated toothpastes and nano-hydoxyapatite toothpastes. Pros and cons of each one them were mentioned. In order to compare the answers, pivot tables have been produced.

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Internet acces * Interested in the Use of a Nanohydroxyapatite Toothpaste

Exclusion criteria

* Age \< 18 years * Peoples who no lives in France

Design outcomes

Primary

MeasureTime frameDescription
Number of people interested in using toothpaste based on nano-hydroxyapatite1 dayNumber of people interested in using toothpaste based on nano-hydroxyapatite

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026